GleamWall
中文EN

SCNX Scienture Holdings, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1382574 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY127.4%
TTM net income YoY-96.3%
TTM EPS YoY144.2%
Revenue 3-yr CAGR-24.9%
Net income 3-yr CAGR—

Margins

Gross margin78.5%
Operating margin-2,788.5%
Net margin-2,715.9%
FCF margin—
EBITDA margin-2,662.9%

Returns

ROE-57.1%
ROA-47.1%
ROIC (approx.)-47.3%
Asset turnover0.02x

Leverage & solvency

Liabilities / assets32.6%
Debt / equity0.00x
Current ratio1.10x
Interest coverage-25.26x

Cash quality & payout

Operating cash flow / net income0.36x
Accruals ratio-30.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$431,609$136,643
Cost of revenue$100,127$130,638
Gross profit$331,482$6,005
R&D expense$1.96M$2.24M
SG&A expense$7.93M$6.68M
Operating income-$42.59M-$14.70M
Interest expense$4.08M$1.34M
Pretax income-$43.51M-$18.78M
Income tax-$1.99M-$534,396
Net income-$41.51M$9.07M
EBITDA-$42.10M-$14.70M
EPS (basic)-2.702.69
EPS (diluted)-2.702.48
Weighted avg. shares (diluted)15.35M3.65M
Banking
Deposits$1.18M—
Balance sheet
Cash & equivalents$6.66M$308,096
Receivables$731,328$11,106
Inventory$213,408—
Current assets$7.92M$6.31M
PP&E, net$15,500$17,500
Goodwill—$21.37M
Intangibles$70.97M$76.40M
Total assets$84.18M$104.85M
Current liabilities$2.74M$7.91M
Long-term debt—$2.90M
Total debt—$2.90M
Total liabilities$14.06M$25.78M
Shareholders' equity$70.12M$79.07M
Net debt—$2.59M
Shares outstanding1.63M8.75M
Cash flow statement
Operating cash flow-$13.38M-$14.27M
Capital expenditure—$12,000
Free cash flow—-$14.28M
Investing cash flow—$27.55M
Financing cash flow$19.73M-$12.98M
Depreciation & amortization$491,781$2,000
Stock-based compensation$2.07M$25,584
Dividends paid—$14.86M

Free plan shows the latest 2 periods; Pro shows all 13 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.